跳至主要内容
临床试验/CTRI/2011/05/001767
CTRI/2011/05/001767尚未招募4 期

Assessment of Interleukin 1β levels and clinical effects of curcumin gel in an experimental gingivitis model. A randomized double blind placebo controlled clinical trial - NI

Shaju Jacob P0 个研究点目标入组 20 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Systemically healthy adults between 20 and 24 years of age with healthy periodontium (no sites with 2mm of probing depth.

排除标准

  • Pregnancy, on antibiotics, on antiinflammatory drugs.

研究者

发起方
Shaju Jacob P

相似试验

进行中(未招募)
1 期
A single centre phase II study of Interleukin 1 receptor antagonist in the treatment of severe Traumatic Brain Injury - Interleukin-1 Receptor Antagonist in Severe Traumatic Brain Injury
EUCTR2005-005707-42-GBCambridge University Hospitals NHS Foundation Trust and University of Cambridge20
尚未招募
不适用
Relationship between levels of Interleukin-1a in gum fluid and the development of root resorption after dental injury.
CTRI/2024/07/070145nithiyalakshmi kanagaraj
尚未招募
不适用
A clinical study to evaluate the levels of inflammatory markers around mini-implants which are used during orthodontic treatment.
CTRI/2018/05/013863Bianca B Rodrigues
进行中(未招募)
1 期
Investigation of the effect of Interleukin-1 receptor antagonist (IL-1ra) on markers of inflammation in non-ST elevation acute coronary syndromes - MRC-ILA-HEART studyWe wish to investigate Acute coronary syndromes (ACS). These are caused by blockages in the main arteries that supply the heart as a result of a process called atherosclerosis. These blockages prevent blood flow down the artery and therefore prevent the heart muscle getting the blood and oxygen that it needs to survive and function. They account for 15% of all deaths in the UK and are associated with considerable long term consequences among survivors.MedDRA version: 8.1 Level: PT Classification code 10051592 Term: Acute coronary syndrome
EUCTR2006-001767-31-GBniversity of Sheffield186
已完成
2 期
Interleukin-1 receptor antagonist in severe traumatic brain injuryTraumatic brain injuryInjury, Occupational Diseases, PoisoningIntracranial injury
ISRCTN88597330Cambridge University Hospitals NHS Foundation Trust (UK)26
A Clinical Trial to test a turmeric based product... | 临床试验